Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500®company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since its founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and advanced technology campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The trusted partner to approximately 825 tenants, Alexandria has a total market capitalization of $30.6 billion and an asset base in North America of 74.9 million SF as of June 30, 2023, which includes 41.1 million RSF of operating properties and 5.3 million RSF of Class A/A+ properties undergoing construction, 9.4 million RSF of near-term and intermediate-term development and redevelopment projects, and 19.1 million SF of future development projects. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in life science, agtech, and advanced technology campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, agrifoodtech, climate innovation, and technology companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Highlights (as of June 30, 2023)
Strong and flexible balance sheet
- $6.3 billion liquidity
- No debt maturities prior to 2025
- 13.4 years weighted-average remaining debt term
Operating asset base
- 41.1 million RSF of operating properties with solid occupancy across key locations of 93.6%
Visible, multiyear, highly leased value-creation
pipeline
- Delivers annual incremental net operating income of $58 million commencing during 2Q23 and drives future annual incremental net operating income aggregating $605 million
Strong core operating metrics
- Favorable triple net lease structure with annual rent escalations
REIT industry-leading client base of approximately 825 tenants
- High-quality and diverse tenant mix across the life science, agtech, and technology industries
Mission-critical infrastructure
-
Generic, reusable, re-leasable,
and valuable laboratory improvements
-
High barriers to exit given
significant investment by tenants coupled with FDA requirements
|
|
|
Financial Information
Alexandria Real Estate Equities is a Real Estate Investment Trust
(REIT) with strong cash flow and an investment-grade balance sheet
capitalizing on the long-term growth potential of the life science
industry.
More
|
|